Publications

  1. Phillips HR, Fetzer JR, Bhattarai S, Perneth SA, Codipilly DC, Ebner DW, Bledsoe AC, Kamboj A, Schupack DA, Chedid V, Coelho-Prabhu N, Snyder D, Ravi K, Buller K, Leggett CL. Computer-assisted classification of the squamocolumnar junction. Gastrointest Endosc. 2025 Aug; 102 (2):245-251 Epub 2025 Jan 18
    View PubMed
  2. Ebner DW, Johnson HA, Estes C, Johnson WK, Khan RS, Thompson G, Kong J, Camardo M, Dore M, Vahdat V, Fendrick AM, Limburg PJ, Kisiel JB. Multi-Target Stool DNA and the Fecal Immunochemical Test: A Systematic Review and Meta-Analysis on Test Performances. Am J Prev Med. 2025 Aug; 69 (2):107654 Epub 2025 May 14
    View PubMed
  3. Chamberlain AM, Ebner DW, Jenkins GD, Greene M, Finney Rutten LJ. Follow-up Colorectal Cancer Screening After Negative-Result and Positive-Result Multitarget Stool DNA Tests: A Population-Based Study in Southeast Minnesota. Mayo Clin Proc Innov Qual Outcomes. 2025 Apr; 9 (2):100599 Epub 2025 Feb 26
    View PubMed
  4. Greene M, Pew T, Dore M, Ebner DW, Ozbay AB, Johnson WK, Kisiel JB, Fendrick AM, Limburg P. Re-screening adherence to multi-target stool DNA test for colorectal cancer: real-world study in a large national population. Int J Colorectal Dis. 2025 Feb 24; 40 (1):48
    View PubMed
  5. Le QA, Kiener T, Johnson HA, Li KH, Limburg PJ, Fendrick AM, Kisiel JB, Ebner DW. Adherence to recommended blood-based screening tests for cancer and chronic diseases: A systematic literature review. Prev Med. 2025 Feb; 191:108213 Epub 2024 Dec 24
    View PubMed
  6. Greene M, Stieber B, Ozbay AB, Ebner D, Fendrick AM, Karlitz JJ. Adherence to Follow-Up Colonoscopy After a Positive Stool-Based Test in Patients Aged 45-49 Years: Real-World Differences Between Multitarget Stool DNA Testing and Fecal Immunochemical or Fecal Occult Blood Testing. Gastro Hep Adv. 2025; 4 (9):100706 Epub 2025 May 16
    View PubMed
  7. Ebner DW, Finney Rutten LJ, Miller-Wilson LA, Markwat N, Vahdat V, Ozbay AB, Limburg PJ. Trends in Colorectal Cancer Screening from the National Health Interview Survey: Analysis of the Impact of Different Modalities on Overall Screening Rates. Cancer Prev Res (Phila). 2024 Jun 4; 17 (6):275-280
    View PubMed
  8. Ebner DW, Kisiel JB, Fendrick AM, Estes C, Li K, Vahdat V, Limburg PJ. Estimated Average-Risk Colorectal Cancer Screening-Eligible Population in the US. JAMA Netw Open. 2024 Mar 4; 7 (3):e245537 Epub 2024 Mar 04
    View PubMed
  9. Kisiel JB, Fendrick AM, Ebner DW, Ozbay AB, Vahdat V, Estes C, Limburg PJ. Estimated impact and value of blood-based colorectal cancer screening at varied adherence compared with stool-based screening. J Med Econ. 2024 Jan-Dec; 27 (1):746-753 Epub 2024 May 13
    View PubMed
  10. Greene M, Pew T, Le Q, Philp A, Johnson WK, Ozbay AB, Kisiel J, Dore M, Ebner D, Fendrick AM, Limburg P. Member Adherence to a Health Insurer-Sponsored Gap Closure Program Using Multi-Target Stool DNA Test for Colorectal Cancer Screening. J Prim Care Community Health. 2024 Jan-Dec; 15:21501319241305958
    View PubMed
  11. Fendrick AM, Kisiel JB, Brooks D, Vahdat V, Estes C, Ebner DW, Limburg P. A Call to Action to Increase Uptake of Follow-Up Colonoscopy After Initial Positive Stool-Based Colorectal Cancer Screening. Popul Health Manag. 2023 Dec; 26 (6):448-450 Epub 2023 Nov 07
    View PubMed
  12. Ebner DW, Burger KN, Mahoney DW, Broderick BT, Eckmann JD, Devens ME, Lowrie KL, League JB, Bering J, Kahn A, Rodriguez EA, Prichard DO, Wallace MB, Kane SV, Leighton JA, Buttar NS, Rutten LJF, Gurudu SR, Kisiel JB. Neoplasia Diagnosis After Multi-target Stool DNA Is Enhanced Among Lowest Baseline Detectors. Dig Dis Sci. 2023 Sep; 68 (9):3721-3731 Epub 2023 July 24
    View PubMed
  13. Ebner DW, Rushlow D, Mou J, Porter K, Finney Rutten LJ, Limburg P, Sancar F, Imperiale TF. Stool-Based Colorectal Cancer Screening Test Performance Characteristics in Those With and Without Hemorrhoids. Mayo Clin Proc Innov Qual Outcomes. 2023 Aug; 7 (4):320-326 Epub 2023 July 19
    View PubMed
  14. Voss JK, Ebner DW, Burger KN, Mahoney DW, Devens ME, Lowrie KL, Kisiel JB. Multitarget Stool DNA Testing Has High Positive Predictive Value for Colorectal Neoplasia on the Second Round of Testing. Clin Gastroenterol Hepatol. 2023 Aug; 21(9):2399-2406. Epub 2023 Jan 06.
    View PubMed
  15. Guerrero Vinsard D, Bruining DH, East JE, Ebner D, Kane SV, Kisiel JB, Leighton JA, Lennon RJ, Loftus EV Jr, Malik T, Picco M, Raffals L, Ramos GP, Santiago P, Coelho-Prabhu N. Interobserver agreement of the modified Paris classification and histology prediction of colorectal lesions in patients with inflammatory bowel disease. Gastrointest Endosc. 2023 Apr; 97 (4):790-798.e2 Epub 2022 Nov 17
    View PubMed
  16. Ebner D, Kisiel J, Barnieh L, Sharma R, Smith NJ, Estes C, Vahdat V, Ozbay AB, Limburg P, Fendrick AM. The cost-effectiveness of non-invasive stool-based colorectal cancer screening offerings from age 45 for a commercial and medicare population. J Med Econ. 2023 Jan-Dec; 26 (1):1219-1226 Epub 2023 Oct 06
    View PubMed
  17. Ebner DW, Burger KN, Broderick B, Mahoney DW, Kellogg TA, Acosta A, Kisiel JB. Positive Predictive Value for Multitarget Stool DNA After Bariatric and Metabolic Surgery. Gastro Hep Adv. 2023; 2 (7):902-910 Epub 2023 July 01
    View PubMed
  18. Ebner DW, Eckmann JD, Burger KN, Mahoney DW, Whitaker TJ, Petersen IA, Kisiel JB. High Positive Predictive Value of Multitarget Stool DNA After Aerodigestive Tract Radiotherapy. Gastro Hep Adv. 2022; 1 (5):746-754 Epub 2022 May 16
    View PubMed
  19. Ebner DW, Eckmann JD, Burger KN, Mahoney DW, Bering J, Kahn A, Rodriguez EA, Prichard DO, Wallace MB, Kane SV, Finney Rutten LJ, Gurudu SR, Kisiel JB. Detection of Postcolonoscopy Colorectal Neoplasia by Multi-target Stool DNA. Clin Transl Gastroenterol. 2021 Jun 18; 12(6):e00375.
    View PubMed
  20. Ebner DW, Kisiel JB. Stool-Based Tests for Colorectal Cancer Screening: Performance Benchmarks Lead to High Expected Efficacy. Curr Gastroenterol Rep. 2020 Jun 3; 22 (7):32 Epub 2020 June 03
    View PubMed
  21. Eckmann JD, Ebner DW, Bering J, Kahn A, Rodriguez E, Devens ME, Lowrie KL, Doering K, Then S, Burger KN, Mahoney DW, Prichard DO, Wallace MB, Gurudu SR, Finney LJ, Limburg P, Berger B, Ahlquist DA, Kisiel JB. Multitarget Stool DNA Screening in Clinical Practice: High Positive Predictive Value for Colorectal Neoplasia Regardless of Exposure to Previous Colonoscopy. Am J Gastroenterol. 2020 Apr; 115 (4):608-615
    View PubMed
  22. Eckmann JD, Ebner DW, Kisiel JB. Multi-Target Stool DNA Testing for Colorectal Cancer Screening: Emerging Learning on Real-world Performance. Curr Treat Options Gastroenterol. 2020 Mar; 18 (1):109-119 Epub 2020 Jan 21
    View PubMed
  23. Ebner DW, Hu M, Poterucha TH. 29-Year-Old Woman With Fever and Bilateral Lower Extremity Lesions. Mayo Clin Proc. 2018 Nov; 93 (11):1659-1663 Epub 2018 Sept 27
    View PubMed
  24. Ebner DW, Al-Bawardy B, Sweetser S. Late-Onset Biallelic Mismatch Repair Deficiency Syndrome. Clin Gastroenterol Hepatol. 2018 Mar; 16 (3):e31-e32 Epub 2017 June 07
    View PubMed
  25. Ebner D, Smith K, DeSimone D, Sohail MR. Cranial neuropathy and severe pain due to early disseminated Borrelia burgdorferi infection. BMJ Case Rep. 2018 Jan 23; 2018
    View PubMed